Choose the brand aligned with your industry so we can best serve your needs.
For researchers, scientists, and technical professionals: Your one-stop shop for the complete range of laboratory, production, and safety products and services.
Products for use in the clinical diagnosis of viral infections, including SARS-CoV-2, the virus that causes COVID-19, by simultaneously measuring multiple analytes from a single sample.
Test Pack contains tests that deliver rapid molecular results for flu and COVID-19 in minutes at the point of care. It helps clinicians make timely treatment decisions with accuracy, and ease of use.
The cobas SARS-CoV-2 & Influenza A/B nucleic acid test for use on the cobas Liat System is a multiplex real-time polymerase chain reaction (PCR) test that detects and differentiates SARS-CoV-2, Influenza A, and Influenza B.
A multiplex real-time PCR solution that contains the assay, master mix, and controls needed for the simultaneous detection of RNA from COVID-19, influenza A, influenza B, and RSV in extracted nasopharyngeal swab specimens.
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
OSOM Flu SARS-CoV-2 Combo Test is a lateral flow in vitro diagnostic for rapid and simultaneous detection and differentiation of influenza A, influenza B, and SARS-CoV-2 antigens for Healthcare providers. For Emergency Use Authorization Only.
Lateral flow immunochromatographic assay intended for the qualitative detection and differentiation of influenza A, and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigens. Box of 25 test cassettes.
The cobas™ liat SARS-CoV-2, Influenza A/B and RSV nucleic acid test for use on the cobas Liat System is a multiplex real-time polymerase chain reaction (PCR) test that detects and differentiates SARS-CoV-2, Influenza A, Influenza B and RSV in nasopharyngeal or anterior nasal swab specimens.
Uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from influenza A and influenza B, and SARS-CoV-2. Allows for testing of patients suspected of influenza A, influenza B, and COVID-19/2019-nCoV at the Point of Care.
Ready-to-use external controls developed to confirm correct test operation and performance when used with the StatID PRO COVID-19/Flu A and B test kit.